Millennium Pharmacon International Tbk PT operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Millennium Pharmacon International Tbk PT with three other
drug stores in Asia:
Tibet Rhodiola Pharmaceutical Holding Company
sales of 1.03 billion Chinese Renmimbi [US$146.36 million]
of which 72%
was Pharmaceutical Business Trade),
Kingworld Medicines Group Limited
(1.08 billion Chinese Renmimbi [US$153.62 million]
of which 90%
was Distribution sales of pharmaceutical and), and
Sinco Pharmaceuticals Holdings Ltd
based in Hong Kong
(1.13 billion Hong Kong Dollars [US$144.12 million]
of which 100%
was Sale of pharmaceutical products).
Millennium Pharmacon International Tbk PT reported sales of 2.38 trillion Indonesian Rupiahs (US$168.71 million)
December of 2018.
increase of 12.6%
versus 2017, when the company's sales were 2.11 trillion Indonesian Rupiahs.
Sales at Millennium Pharmacon International Tbk PT have increased during each of the previous five years
(and since 2013, sales have increased a total of 81%).